G. Rossetti

发表

Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis

S. Mustjoki, T. Brümmendorf, J. Panse, 2020, bioRxiv.

Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicine

T. Haferlach, T. Brümmendorf, P. Carloni, 2015, Leukemia.